• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recent Advances in Predicting Mortality and Progression of Systemic Sclerosis-Associated Interstitial Lung Disease.

作者信息

Park Moo Suk

机构信息

Division of Pulmonology, Department of Internal Medicine, Institute of Chest Diseases, Severance Hospital, Younsei University Health System, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Tuberc Respir Dis (Seoul). 2020 Oct;83(4):326-328. doi: 10.4046/trd.2020.0100. Epub 2020 Sep 9.

DOI:10.4046/trd.2020.0100
PMID:32898968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7515672/
Abstract
摘要

相似文献

1
Recent Advances in Predicting Mortality and Progression of Systemic Sclerosis-Associated Interstitial Lung Disease.系统性硬化症相关间质性肺疾病死亡率及病情进展预测的最新进展
Tuberc Respir Dis (Seoul). 2020 Oct;83(4):326-328. doi: 10.4046/trd.2020.0100. Epub 2020 Sep 9.
2
Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.系统性硬皮病相关间质性肺病的治疗：现有和新兴疗法的综述。
Ann Am Thorac Soc. 2016 Nov;13(11):2045-2056. doi: 10.1513/AnnalsATS.201606-426FR.
3
Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.系统性硬化症（硬皮病）间质性肺疾病的诊断和治疗新进展：综述。
Clin Exp Rheumatol. 2011 Mar-Apr;29(2 Suppl 65):S66-74. Epub 2011 May 13.
4
New developments in scleroderma interstitial lung disease.硬皮病相关性间质性肺病的新进展
Curr Opin Rheumatol. 2005 Nov;17(6):737-45. doi: 10.1097/01.bor.0000181534.67685.5a.
5
Systemic sclerosis-associated interstitial lung disease.系统性硬皮病相关性间质性肺疾病。
Lancet Respir Med. 2020 Mar;8(3):304-320. doi: 10.1016/S2213-2600(19)30480-1. Epub 2020 Feb 27.
6
Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy.系统性硬化症中的间质性肺疾病：病理生理学、治疗的现状与新进展
Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):266-77. doi: 10.2174/187152812800959013.
7
Recent progress in systemic sclerosis-interstitial lung disease.系统性硬皮病-间质性肺病的最新进展。
Curr Opin Rheumatol. 2018 Nov;30(6):570-575. doi: 10.1097/BOR.0000000000000544.
8
Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease.评估系统性硬化症相关间质性肺病的死亡率模型。
Lung. 2018 Aug;196(4):409-416. doi: 10.1007/s00408-018-0126-6. Epub 2018 May 21.
9
Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.系统性硬化症相关间质性肺疾病患者的支气管肺泡灌洗细胞谱不能预测疾病进展。
Arthritis Rheum. 2007 Jun;56(6):2005-12. doi: 10.1002/art.22696.
10
[Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].[卡托普利延缓自发性动脉高血压和阿霉素肾病大鼠慢性肾功能不全的进展]
Srp Arh Celok Lek. 2002 Mar-Apr;130(3-4):73-80. doi: 10.2298/sarh0204073j.

本文引用的文献

1
Short-Term Lung Function Changes and Predictors of Progressive Systemic Sclerosis-Related Interstitial Lung Disease.短期肺功能变化及进行性系统性硬化症相关间质性肺病的预测因素
Tuberc Respir Dis (Seoul). 2020 Oct;83(4):312-320. doi: 10.4046/trd.2020.0043. Epub 2020 Jul 15.
2
Risk prediction model in rheumatoid arthritis-associated interstitial lung disease.类风湿关节炎相关间质性肺疾病的风险预测模型。
Respirology. 2020 Dec;25(12):1257-1264. doi: 10.1111/resp.13848. Epub 2020 May 22.
3
Predictors of progression in systemic sclerosis patients with interstitial lung disease.系统性硬皮病合并间质性肺病患者进展的预测因素。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.02026-2019. Print 2020 May.
4
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.尼达尼布治疗系统性硬化症相关间质性肺疾病。
N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20.
5
The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease.ILD-GAP 风险预测模型在肌炎相关性间质性肺疾病中的表现不佳。
Respir Med. 2019 Apr;150:63-65. doi: 10.1016/j.rmed.2019.02.015. Epub 2019 Feb 21.
6
Interstitial lung disease associated with systemic sclerosis (SSc-ILD).系统性硬化症相关的间质性肺疾病（SSc-ILD）。
Respir Res. 2019 Jan 18;20(1):13. doi: 10.1186/s12931-019-0980-7.
7
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.系统性硬化症患者的间质性肺病短期进展可预测两个独立临床试验队列的长期生存。
Ann Rheum Dis. 2019 Jan;78(1):122-130. doi: 10.1136/annrheumdis-2018-213708. Epub 2018 Nov 8.
8
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.系统性硬化症患者间质性肺病进展的预测：SPAR 模型。
Ann Rheum Dis. 2018 Sep;77(9):1326-1332. doi: 10.1136/annrheumdis-2018-213201. Epub 2018 Jun 6.
9
ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease.ILD-NSCLC-GAP 指数评分和分期系统，用于患有非小细胞肺癌和间质性肺疾病的患者。
Lung Cancer. 2018 Jul;121:48-53. doi: 10.1016/j.lungcan.2018.04.023. Epub 2018 Apr 26.
10
Comparison of CPI and GAP models in patients with idiopathic pulmonary fibrosis: a nationwide cohort study.特发性肺纤维化患者中 CPI 和 GAP 模型的比较：一项全国性队列研究。
Sci Rep. 2018 Mar 19;8(1):4784. doi: 10.1038/s41598-018-23073-3.